Spectinomycin
From Wikipedia, the free encyclopedia
Spectinomycin
|
|
Systematic (IUPAC) name | |
(2R,4aR,5aR,6S,7S,8R,9S,9aR,10aS)- 4a,7,9-trihydroxy-2-methyl-6,8-bis(methylamino) decahydro-4H-pyrano[2,3-b][1,4]benzodioxin-4-one |
|
Identifiers | |
CAS number | |
ATC code | J01 |
PubChem | |
DrugBank | |
Chemical data | |
Formula | C14H24N2O7 |
Mol. mass | 332.35 g/mol |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
B(US) |
Legal status |
not available in US |
Routes | ? |
Spectinomycin (marketed as the hydrochloride salt spectinomycin hydrochloride under the trade name Trobicin) is an aminocyclitol antibiotic produced by the bacterium Streptomyces spectabilis.
[edit] Mechanism
It binds to the 30S ribosomal subunit in invading bacteria and interrupts protein synthesis.
[edit] Uses
It is given by injection to treat gonorrhea, especially in patients who are allergic to penicillins.
[edit] Side effects
Side effects include itching, chills, stomach-ash, and red rash.
|
|